BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11812509)

  • 1. Lack of effects of acute estradiol on mood in postmenopausal women.
    Schleifer LA; Justice AJ; de Wit H
    Pharmacol Biochem Behav; 2002; 71(1-2):71-7. PubMed ID: 11812509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women.
    Newhouse PA; Dumas J; Hancur-Bucci C; Naylor M; Sites CK; Benkelfat C; Young SN
    Neuropsychopharmacology; 2008 Jun; 33(7):1514-27. PubMed ID: 17700646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels.
    Wolf OT; Kudielka BM; Hellhammer DH; Törber S; McEwen BS; Kirschbaum C
    Psychoneuroendocrinology; 1999 Oct; 24(7):727-41. PubMed ID: 10451908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.
    Hamidovic A; Childs E; Conrad M; King A; de Wit H
    Drug Alcohol Depend; 2010 Jun; 109(1-3):175-80. PubMed ID: 20176450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
    Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
    J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.
    Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH
    Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methods for the assessment of central nervous system stimulant response after dextroamphetamine administration to healthy male volunteers.
    Slattum PW; Venitz J; Barr WH
    J Clin Pharmacol; 1996 Nov; 36(11):1039-50. PubMed ID: 8973993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amphetamine on reactivity to emotional stimuli.
    Wardle MC; de Wit H
    Psychopharmacology (Berl); 2012 Mar; 220(1):143-53. PubMed ID: 21947316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive response to estradiol in postmenopausal women is modified by high cortisol.
    Baker LD; Asthana S; Cholerton BA; Wilkinson CW; Plymate SR; Green PS; Merriam GR; Fishel MA; Watson GS; Cherrier MM; Kletke ML; Mehta PD; Craft S
    Neurobiol Aging; 2012 Apr; 33(4):829.e9-20. PubMed ID: 21855173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.
    Björn I; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström G; Bäckström T
    J Clin Endocrinol Metab; 2003 May; 88(5):2026-30. PubMed ID: 12727949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study.
    Baker LD; Sambamurti K; Craft S; Cherrier M; Raskind MA; Stanczyk FZ; Plymate SR; Asthana S
    Am J Geriatr Psychiatry; 2003; 11(2):239-44. PubMed ID: 12611754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
    Björn I; Bixo M; Nöjd KS; Collberg P; Nyberg S; Sundström-Poromaa I; Bäckström T
    Gynecol Endocrinol; 2002 Feb; 16(1):1-8. PubMed ID: 11915576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
    Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.